Can Caudal Dexmedetomidine Provide Effective Analgesia?

Launched by BENHA UNIVERSITY · Jun 5, 2023

Keywords

ClinConnect Summary

This clinical trial is studying whether a medication called caudal dexmedetomidine can effectively relieve pain during certain surgeries for young children, specifically inguinoscrotal surgeries. The trial will involve children aged 1 to 6 years who are classified as ASA-I or ASA-II, which means they are generally healthy or have mild health issues. The goal is to find out if dexmedetomidine can provide good pain relief when used by itself, rather than in combination with another pain medication called bupivacaine.

In this study, 50 children will be randomly divided into two groups. One group will receive bupivacaine for pain relief, while the other group will receive dexmedetomidine. Participants can expect to receive either of these medications after they are put under general anesthesia for their surgery. It’s important to note that children cannot participate if their parents refuse, if they have allergies to the study medications, or if they have certain medical conditions. This research aims to improve pain management options for young patients undergoing surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ASA-I and ASA-II pediatric patients (age :1-6 years old)
• • Inguinoscrotal surgeries
• Exclusion Criteria:
• • Patient's parent's refusal
• • Unable to give consent
• • Known allergy to the study medications
• • Coagulopathies or on anticoagulant medications
• • ASA-III or ASA-IV